Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anglaret

Showing results (241-250 of 267) with videos related to

Pageof 27
Sort By:
Trials|November 9, 2022
Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trialThomas Maitre, Maryline Bonnet, Alexandra Calmy, et al.
Plos Neglected Tropical Diseases|February 24, 2017
Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targetedThi Huyen Tram Nguyen, Jérémie Guedj, Xavier Anglaret, et al.
Lancet (London, England)|October 9, 2007
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trialThierry Facon, Jean Yves Mary, Cyrille Hulin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Ebola Virus Persistence in Breast Milk After No Reported Illness: A Likely Source of Virus Transmission From Mother to ChildDaouda Sissoko, Mory Keïta, Boubacar Diallo, et al.
The Lancet. Global Health|March 19, 2021
Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort studyAlexandre Duvignaud, Marie Jaspard, Ijeoma Chukwudumebi Etafo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 17, 2021
Clinical presentation, outcomes and factors associated with mortality: A prospective study from three COVID-19 referral care centres in West AfricaMarie Jaspard, Mamadou Saliou Sow, Sylvain Juchet, et al.
Trials|October 14, 2020
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial)Alexandre Duvignaud, Edouard Lhomme, Thierry Pistone, et al.
Eclinicalmedicine|October 20, 2022
Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: Results from the EVISTA cohort in the Democratic Republic of the CongoMarie Jaspard, Sabue Mulangu, Sylvain Juchet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2013
Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experienceHervé Avet-Loiseau, Cyrille Hulin, Loic Campion, et al.
Haematologica|November 16, 2014
Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trialPhilippe Rodon, Cyrille Hulin, Brigitte Pegourie, et al.
Pageof 27

Showing results (241-250 of 267) with videos related to

Sort By:
Pageof 27
Trials|November 9, 2022
Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trialThomas Maitre, Maryline Bonnet, Alexandra Calmy, et al.
Plos Neglected Tropical Diseases|February 24, 2017
Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targetedThi Huyen Tram Nguyen, Jérémie Guedj, Xavier Anglaret, et al.
Lancet (London, England)|October 9, 2007
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trialThierry Facon, Jean Yves Mary, Cyrille Hulin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Ebola Virus Persistence in Breast Milk After No Reported Illness: A Likely Source of Virus Transmission From Mother to ChildDaouda Sissoko, Mory Keïta, Boubacar Diallo, et al.
The Lancet. Global Health|March 19, 2021
Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort studyAlexandre Duvignaud, Marie Jaspard, Ijeoma Chukwudumebi Etafo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 17, 2021
Clinical presentation, outcomes and factors associated with mortality: A prospective study from three COVID-19 referral care centres in West AfricaMarie Jaspard, Mamadou Saliou Sow, Sylvain Juchet, et al.
Trials|October 14, 2020
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial)Alexandre Duvignaud, Edouard Lhomme, Thierry Pistone, et al.
Eclinicalmedicine|October 20, 2022
Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: Results from the EVISTA cohort in the Democratic Republic of the CongoMarie Jaspard, Sabue Mulangu, Sylvain Juchet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2013
Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experienceHervé Avet-Loiseau, Cyrille Hulin, Loic Campion, et al.
Haematologica|November 16, 2014
Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trialPhilippe Rodon, Cyrille Hulin, Brigitte Pegourie, et al.
Pageof 27